The only FDA-Approved treatment for Lysosomal Acid Lipase Deficiency (LAL-D)
KANUMA® (sebelipase alfa) is a prescription medication used to treat people with a diagnosis of LAL-D.
Kanuma® (sebelipase alfa) is administered via infusion
KANUMA is indicated for the treatment of people with a diagnosis of LAL-D and is administered
as an infusion by a healthcare professional.
For more information on KANUMA infusions:
Download Infusion Brochure
Getting Started on Kanuma
KANUMA is indicated for the treatment of patients with a diagnosis of LAL-D. Once your doctor has determined that KANUMA is right for you, sign up for OneSource™, a personalized patient support program from Alexion Pharmaceuticals.
There are 2 ways to get access to OneSource:
Call 1-888-765-4747
Get in touch with a OneSource Case Manager.
Download the OneSource enrollment form below
Print this form, sign it, and submit it to OneSource. Someone will be in touch within the next business day.
Submit via email: OneSource@alexion.com
Submit via fax: 1-800-420-5150
Download OneSource enrollment form
KANUMA support by OneSource™
With our experience and resources, we’re here to help you feel supported every step of the way. Here’s an overview of the services we offer.
CoPay Program
Here are some additional services we provide to help support you with KANUMA
If you have Medicare, Medicaid, or another federal- or state-funded insurance plan, we can connect you to third-party resources that may be able to help with financial assistance.
If you have commercial insurance, you may be eligible for the Alexion OneSource CoPay Program, which may be able to help cover some out-of-pocket treatment costs.
To be eligible for the CoPay Program, you must:
- Be signed up for patient services through OneSource
- Have commercial insurance (not part of a federal- or state-funded healthcare program)
- Be prescribed KANUMA for an FDA-approved indication
- Reside in the United States or its territories
Talk to your healthcare provider or OneSource Case Manager for more information about financial assistance.